GlassScriptPhysician profile
Jeffrey P Lake
NPI 1326006024
$3,290.93
in general payments reported to CMS, 2019-2025
26 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $1,030 · 2021: $150 · 2022: $723 · 2023: $56.22 · 2024: $228 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,056.56 | 2019-2024 | |
| Medical Device Business Services, INC. | $500.00 | 2020 | |
| Prescient Surgical | $274.13 | 2019 | |
| Medtronic, INC. | $231.42 | 2022-2025 | Signia |
| Thd America, INC. | $192.43 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.50 | 2019-2021 | |
| Acelrx Pharmaceuticals, INC. | $123.34 | 2019 | |
| Aroa Biosurgery Incorporated | $91.93 | 2023-2025 | |
| Ethicon US, LLC | $80.63 | 2020-2022 | |
| Conmed Corporation | $77.11 | 2025 | Airseal, Conmed Specimen Retrieval |
| Davol INC. | $60.02 | 2019-2025 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $55.15 | 2021-2023 | Gattex |
| Acell, INC. | $52.74 | 2020 | |
| Allergan, INC. | $48.37 | 2020-2022 | |
| Becton, Dickinson and Company | $32.74 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $32.15 | 2022 | |
| Biotissue Holdings INC. | $29.52 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.09 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $27.06 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $26.37 | 2022 | |
| Convatec INC. | $25.18 | 2021 | |
| Vioptix INC | $25.04 | 2020 | |
| Janssen Biotech, INC. | $22.66 | 2019 | |
| Trevena, INC. | $22.50 | 2022 | |
| Merck Sharp & Dohme LLC | $18.00 | 2019 | |
| Medspira, LLC | $14.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.